Brent Warner

Brent Warner

Chief Executive Officer at
Protego Biopharma, Inc.
42 year
Health Technology
Consumer Services
Commercial Services

Profile

Brent J.
Warner
is currently Chief Executive Officer & Director at Protego Biopharma, Inc. since 2024.
Formerly, Mr. Warner was President-Gene Therapy at Poseida Therapeutics, Inc. from 2022 to 2024 and Vice President-Gene Therapy & Rare Disease at Novartis Pharmaceuticals Canada, Inc. from 2019 to 2022.
Mr. Warner completed undergraduate and MBAistration degrees at Northwood University (Michigan).

Brent Warner active positions

CompaniesPositionStart
Chief Executive Officer 01/04/2024

Former positions of Brent Warner

CompaniesPositionEnd
POSEIDA THERAPEUTICS, INC. Corporate Officer/Principal 01/04/2024
Corporate Officer/Principal 01/02/2022
See the detail of Brent Warner's experience

Training of Brent Warner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

4

1st degree connections

4

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies4

Consumer Services

Health Technology

Health Technology

Commercial Services